Bio-Interfaces

Bio-Interfaces

ISSN ---- An International Triannual Journal

Author Guidelines

Thank you for choosing to submit your manuscript to Bio-interfaces. These instructions will ensure your article moves smoothly through peer review, production and publication.

Editorial policy

The submitted articles/materials must not be under consideration for publication anywhere else and abide by the publication and experimentation ethics described below. All received articles are subjected to a double-blind peer-review process. Peer review is obtaining advice on individual manuscripts from reviewers and experts in the field. The editorial board sends articles to at least two potential reviewers, and the Editor-in-Chief approves articles on the advice of those reviewers. After the acceptance of an article, a copyright agreement/license to publish form is sent to the corresponding author(s). After receiving the signed copyright agreement/license to publish form, an uncorrected proof of the manuscript is sent to the corresponding author(s) for final checking. The full article is published open access online immediately after receiving the corrected proof of manuscript from the corresponding author(s). Bio-interfaces publishes three issues per year, and their execution time is April, August and December, respectively, each year. The editorial board takes reasonable responsive measures.when ethical complaints (such as multiple submissions, bogus claims of authorship, plagiarism, fraudulent use of data or the like) are presented concerning a submitted manuscript or published article. Submission should be made through the online submission system of the journal

Ethics of experimentation

It is assumed that the submitted work has been conducted per the biological welfare laws acceptable worldwide and/or laws of the country where the work was undertaken; however, the journal management has the right to reject any manuscript where there is enough reason to believe that necessary laws and procedures have not been followed. All manuscripts which report in vivo experiments or clinical trials on humans or animals must include a written statement in the Materials and Methods section that such work was conducted with the formal approval of the local human subject (patient or relatives/guardians if the patient is dead) or with the formal permission of animal care committees, and that clinical trials have been registered as the legislation requires.

If required, Authors must confirm that all mandatory laboratory health and safety procedures have been complied with within the course of conducting any experimental work reported in the manuscript and that the manuscript contains all appropriate warnings and safety precautions concerning any particular hazards that may be involved in carrying out experiments or procedures described in the manuscript or involved in instructions, materials, or formulae in the manuscript.

The gene sequences should be submitted in a public database (GenBank, EMBL, or DDBJ), and their accession number must be mentioned in the text.

 

Plagiarism Detection

Bio-interfaces takes publication ethics very seriously and abides by the best practice guidance of the Committee on Publication Ethics. Bio-interfaces verify the originality of content submitted before publication. Turnitin checks submitted articles against millions of published articles and billions of web content. Every article is screened on submission, and any that is deemed to overlap more than trivially with other publications will be rejected automatically with no right of appeal.

 

Statement for Competing Interest / Conflict of Interest / Intellectual Property Right

To ensure the objectivity and transparency in research and principles of ethical and professional conduct, authors must certify that they have or have no affiliation with or involvement in any organization or entity with any non-financial interest (such as personal or professional relationships, knowledge) and financial interest (such as educational grants; honoraria; employment, consultancies, or other equity interest; and patent-licensing, including patents and copyrights, whether pending, issued, licensed and/or receiving royalties) in the subject matter or materials discussed in this manuscript. The source of funding and conflict of interest statement must be included in the manuscript at the end before the references section. The names of funding organizations should be written in full; abbreviations should be avoided. See below examples of disclosures:

Funding: This study was funded by X (grant number X).

Conflict of Interest: Author A has received research grants from Company A. Author B has received a speaker honorarium from Company X and owns stock in Company Y. Author C is a member of committee Z.

If no conflict exists, the authors should state that the authors have no conflict of interest.

Article Submission and Processing Charges:All articles accepted and published in Bio-interfaces are fully Open Access: they are immediately freely available to read, download, and share. Submissions will be subject to an APC if accepted and published in the journal: USD 500.

Please note: Article Publication Charges (APCs) are currently waived.